Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

The team

Our people are our strength

Executive leadership team

Oriol Casanovas, PhD.
Co-Founder & interim CEO

Dr. Casanovas is an internationally renowned biomedical researcher with extensive knowledge and experience in basic and translational research focused on determining the consequences of adaptation and resistance to therapies against cancer.

Gabriela Jiménez, PhD.
Co-Founder & COO

Dr. Jiménez has a PhD in Biomedicine from the University of Barcelona and studies BSM, EADA business school and IESE. She is experienced in business development, drug development and biomarker discovery.

Juana Flores, PhD, MBA
CIO

15+ years in corporate strategy and +15 in research
Launched more than 10 innovative products and contributed to 4 M&A..

Advisor team

Itziar Canamasas, PhD.
Business Advisor & Chairwoman

Dr. Canamasas is a highly experienced pharmaceutical executive with a PhD in Tumor Genetics from the University of Mainz and studies at Harvard Business School and IMD Business School.

Bart Huisken, MBA.
Co-Founder & Business Strategy

Business Angel, NED and strategic advisor
Co-founded 7 businesses over 20+ years

Richard Roberts, PhD.
Medicinal Chemistry Advisor

20+ years in drug development


Scott Wilhem
Product Development Strategic Advisor

18 years as the director of oncology discovery at Bayer

Mark Tebbe
Operational and Chemistry Advisor

20+ years in drug development


Todd Snowden
IVD Strategic & Commercial Development Advisor

25+ years in MedTech. IVD expert & biomarker lead

Research team

Our academic founders have played a key role in demonstrating that resistance to cancer therapy occurs in response to adaptive mechanisms of tumor cells.

We are part of the Program Against Cancer Therapeutic Resistance (ProCURE)

We research resistance mechanisms and tumor malignization

We are always looking for new talent to join our team